Variant report
Variant | nsv828648 |
---|---|
Chromosome Location | chr19:56861685-56864862 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:251)
- CpG islands (count:0)
- Chromatin interactive region (count:8)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
(count:8 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr19:56861231..56864651-chr19:56864910..56868187,3 | K562 | blood: | |
2 | chr19:56861231..56863974-chr19:56864374..56866865,3 | K562 | blood: | |
3 | chr19:56668300..56669866-chr19:56860009..56861949,2 | K562 | blood: | |
4 | chr19:56821112..56821613-chr19:56861782..56862434,2 | K562 | blood: | |
5 | chr19:56587879..56588429-chr19:56861518..56862050,2 | MCF-7 | breast: | |
6 | chr19:56825650..56827475-chr19:56859296..56861906,3 | K562 | blood: | |
7 | chr19:56861231..56863974-chr19:56864374..56866865,3 | K562 | blood: | |
8 | chr19:56821792..56823459-chr19:56860076..56862047,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000267429 | TF binding region |
ENSG00000267549 | chromatin interactions |
ENSG00000131848 | chromatin interactions |
ENSG00000167685 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs560472634 | chr19:56861694-56861695 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
2 | rs191934814 | chr19:56861707-56861708 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
3 | rs575497121 | chr19:56861726-56861727 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
4 | rs114517946 | chr19:56861846-56861847 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
5 | rs11671109 | chr19:56861932-56861933 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs12982404 | chr19:56862069-56862070 | Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs540711652 | chr19:56862163-56862164 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs183032881 | chr19:56862196-56862197 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs532655691 | chr19:56862197-56862198 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs200356796 | chr19:56862218-56862219 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs571701858 | chr19:56862226-56862227 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs142779790 | chr19:56862228-56862229 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs562906103 | chr19:56862285-56862286 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs146073173 | chr19:56862320-56862321 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs368741449 | chr19:56862362-56862363 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs186701530 | chr19:56862366-56862367 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs148476723 | chr19:56862367-56862368 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs536021519 | chr19:56862377-56862378 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs141813544 | chr19:56862395-56862396 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs11667517 | chr19:56862467-56862468 | Weak transcription Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs538359400 | chr19:56862587-56862588 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs536827945 | chr19:56862718-56862719 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs574919455 | chr19:56862753-56862754 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs373427546 | chr19:56862869-56862870 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs538525723 | chr19:56862904-56862905 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs75106529 | chr19:56862909-56862910 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs79972086 | chr19:56862910-56862911 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs533765029 | chr19:56862944-56862945 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs560688803 | chr19:56862953-56862954 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs2058318 | chr19:56862976-56862977 | Enhancers Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
31 | rs190378003 | chr19:56862997-56862998 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs562868184 | chr19:56863001-56863002 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs531651787 | chr19:56863027-56863028 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs548576094 | chr19:56863066-56863067 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs560980972 | chr19:56863077-56863078 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs371933795 | chr19:56863107-56863108 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs8109340 | chr19:56863145-56863146 | Enhancers Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs370231943 | chr19:56863167-56863168 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs546351661 | chr19:56863187-56863188 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs77819594 | chr19:56863192-56863193 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs11672336 | chr19:56863207-56863208 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs369252788 | chr19:56863209-56863210 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs139573357 | chr19:56863222-56863223 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs556126006 | chr19:56863249-56863250 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs537402155 | chr19:56863285-56863286 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs554552368 | chr19:56863291-56863292 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs2058319 | chr19:56863306-56863307 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
48 | rs534532305 | chr19:56863307-56863308 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs8109555 | chr19:56863358-56863359 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs577561224 | chr19:56863372-56863373 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Myelodysplastic syndrome | 17634407 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Cancer | 20164919 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Prostate cancer | 18632612 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
Congenital nephrotic syndrome | 18421352 | CNVD |
Astrocytoma | 17934521 | CNVD |
Leukemia | 17361228 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Breast cancer | 17603634 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
renal disease | 20603712 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Salivary gland adenoid cystic carcinoma | 17545515 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Chordoma | 18071362 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Bladder cancer | 21909424 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Wilms tumour | 21544195 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18852474 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Cervical cancer | 21062161 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Prostate cancer | 16573809 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Lung cancer | 18438408 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Neuroblastoma | 20406844 | CNVD |
Breast cancer | 21785460 | CNVD |
Myelofibrosis | 22110671 | CNVD |
T-cell acute lymphoblastic leukemia | 19406988 | CNVD |
Alzheimer''s disease | 22166940 | CNVD |
Heart disease | 21282601 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
Basal cell lymphoma | 19029149 | CNVD |
Diffuse large b-cell lymphoma | 19029149 | CNVD |
Breast cancer | 20409316 | CNVD |
Non-syndromic sensorineural hearing loss | 17289997 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr19:56854200-56863200 | Weak transcription | Brain Dorsolateral Prefrontal Cortex | brain |
2 | chr19:56855000-56870200 | Weak transcription | Duodenum Smooth Muscle | Duodenum |
3 | chr19:56859400-56872800 | Weak transcription | Ovary | ovary |
4 | chr19:56859600-56862400 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
5 | chr19:56859600-56862400 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
6 | chr19:56860000-56862800 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
7 | chr19:56861600-56862000 | Enhancers | Colon Smooth Muscle | Colon |
8 | chr19:56861800-56862000 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
9 | chr19:56862000-56868400 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
10 | chr19:56862400-56863000 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
11 | chr19:56862400-56863400 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
12 | chr19:56862400-56866400 | Weak transcription | Right Atrium | heart |
13 | chr19:56862800-56863400 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
14 | chr19:56863000-56872800 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
15 | chr19:56863800-56864000 | Enhancers | Brain Substantia Nigra | brain |
16 | chr19:56863800-56864600 | Enhancers | HepG2 | liver |
17 | chr19:56864000-56864400 | Enhancers | Brain Hippocampus Middle | brain |
18 | chr19:56864000-56864400 | Weak transcription | Brain Substantia Nigra | brain |
19 | chr19:56864400-56864600 | ZNF genes & repeats | Brain Substantia Nigra | brain |
20 | chr19:56864400-56864800 | ZNF genes & repeats | Liver | Liver |
21 | chr19:56864600-56865600 | Weak transcription | Brain Substantia Nigra | brain |
22 | chr19:56864600-56865800 | Weak transcription | HepG2 | liver |
23 | chr19:56864800-56865400 | Weak transcription | Liver | Liver |